Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.405
-0.145 (-9.35%)
Mar 31, 2025, 10:51 AM EDT - Market open
Cabaletta Bio Stock Forecast
CABA's stock price has decreased by -91.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Cabaletta Bio stock have an average target of 26.13, with a low estimate of 6.00 and a high estimate of 50. The average target predicts an increase of 1,759.79% from the current stock price of 1.41.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 18, 2025.
Analyst Ratings
The average analyst rating for Cabaletta Bio stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 5 | 5 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,679.36% | Feb 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,679.36% | Jan 17, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $15 → $6 | Buy → Hold | Downgrades | $15 → $6 | +327.05% | Dec 20, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $12 → $6 | Buy → Hold | Downgrades | $12 → $6 | +327.05% | Dec 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +1,679.36% | Nov 18, 2024 |
Financial Forecast
Revenue This Year
n/a
from 356.04M
Revenue Next Year
n/a
EPS This Year
-2.60
from -2.34
EPS Next Year
-2.77
from -2.60
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 15.8M | 239.4M | ||
| Avg | n/a | 1.9M | 38.8M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 12,414.4% | ||
| Avg | - | - | 1,926.1% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.64 | -1.66 | -0.60 | ||
| Avg | -2.60 | -2.77 | -2.19 | ||
| Low | -3.19 | -3.55 | -3.92 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.